Nonsurgical management of Chiari malformation type I and syringomyelia and the potential role of inflammation in the pathophysiology of Chiari-associated syrinx: illustrative cases

BACKGROUND Chiari malformation type I (CM-I) is characterized by cerebellar tonsil position ≥ 5 mm below the foramen magnum, which can disrupt CSF flow and lead to syringomyelia. Pro-inflammatory processes have been associated with heightened CNS inflammation and altered CSF dynamics, mechanisms that may contribute to CM-I and syringomyelia pathogenesis, although the precise relationship remains uncertain. Anti-inflammatory interventions, including dietary modification and pharmacological therapies such as metformin, may offer neuroprotective benefits by mitigating neuroinflammation and improving neurological outcomes. OBSERVATIONS The authors describe the cases of 2 pediatric patients with CM-I and syringomyelia who demonstrated clinical and radiographic improvement following anti-inflammatory interventions. Both patients initially presented with symptomatic CM-I, cerebellar tonsil position > 5 mm below the foramen magnum, and syringomyelia. A 7-year-old female was started on a diet intended to reduce inflammation and restrict gluten and sugar and subsequently demonstrated stable tonsil position, reduced syrinx size, and symptomatic improvement of hand paresthesias. A 9-year-old female began metformin therapy and experienced stable tonsil position, reduction in a multiloculated syrinx, and resolution of symptoms. LESSONS These cases suggest that anti-inflammatory interventions may contribute to symptom improvement and syrinx reduction in CM-I–associated syringomyelia, supporting further investigation into inflammation as a therapeutic target in CM-I pathogenesis. https://thejns.org/doi/10.3171/CASE26496

Authors

Institutions

Publication Details

Journal
Journal of Neurosurgery Case Lessons
Published
2026-11-18
DOI
https://doi.org/10.3171/case26496
Primary Topic
Spinal Dysraphism and Malformations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nonsurgical management of Chiari malformation type I and syringomyelia and the potential role of inflammation in the pathophysiology of Chiari-associated syrinx: illustrative cases

Shelei Pan, Vivek P. Gupta, Jennifer Mae Strahle, Farrell K. Landwehr
Journal of Neurosurgery Case Lessons
Spinal Dysraphism and Malformations
article

Nonsurgical management of Chiari malformation type I and syringomyelia and the potential role of inflammation in the pathophysiology of Chiari-associated syrinx: illustrative cases

Shelei Pan, Vivek P. Gupta, Jennifer Mae Strahle, Farrell K. Landwehr
article en

Abstract

BACKGROUND Chiari malformation type I (CM-I) is characterized by cerebellar tonsil position ≥ 5 mm below the foramen magnum, which can disrupt CSF flow and lead to syringomyelia. Pro-inflammatory processes have been associated with heightened CNS inflammation and altered CSF dynamics, mechanisms that may contribute to CM-I and syringomyelia pathogenesis, although the precise relationship remains uncertain. Anti-inflammatory interventions, including dietary modification and pharmacological therapies such as metformin, may offer neuroprotective benefits by mitigating neuroinflammation and improving neurological outcomes. OBSERVATIONS The authors describe the cases of 2 pediatric patients with CM-I and syringomyelia who demonstrated clinical and radiographic improvement following anti-inflammatory interventions. Both patients initially presented with symptomatic CM-I, cerebellar tonsil position > 5 mm below the foramen magnum, and syringomyelia. A 7-year-old female was started on a diet intended to reduce inflammation and restrict gluten and sugar and subsequently demonstrated stable tonsil position, reduced syrinx size, and symptomatic improvement of hand paresthesias. A 9-year-old female began metformin therapy and experienced stable tonsil position, reduction in a multiloculated syrinx, and resolution of symptoms. LESSONS These cases suggest that anti-inflammatory interventions may contribute to symptom improvement and syrinx reduction in CM-I–associated syringomyelia, supporting further investigation into inflammation as a therapeutic target in CM-I pathogenesis. https://thejns.org/doi/10.3171/CASE26496

Journal of Neurosurgery Case LessonsVol. 12(21)
Washington University in St. Louis (US)
Good health and well-being
Spinal Dysraphism and Malformations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon